FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

46011000052107: Swedish [International Organization for Standardization 639-1 code sv] language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 21-Dec 2012. Module: SNOMED CT Sweden NRC maintained module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3604331000052117 Swedish [International Organization for Standardization 639-1 code sv] language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)
3604341000052111 Swedish language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)
4976651000052116 Swedish [International Organization for Standardization 639-1 code sv] language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)
4976631000052113 Swedish language reference set sv Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

384541 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Swedish [International Organization for Standardization 639-1 code sv] language reference set (foundation metadata concept) Is a Language type reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
1413 U Preferred (foundation metadata concept)
143 Preferred (foundation metadata concept)
143,75 Preferred (foundation metadata concept)
144 Preferred (foundation metadata concept)
144,6 Preferred (foundation metadata concept)
145 Preferred (foundation metadata concept)
1473 K Preferred (foundation metadata concept)
149 Preferred (foundation metadata concept)
14q11.2-mikrodeletionssyndromet Preferred (foundation metadata concept)
14q11.2-mikroduplikationssyndromet Preferred (foundation metadata concept)
14q12-mikrodeletionssyndromet Preferred (foundation metadata concept)
14q22q23-mikrodeletionssyndromet Preferred (foundation metadata concept)
14q24.1q24.3-mikrodeletionssyndromet Preferred (foundation metadata concept)
14q32-deletionssyndromet Preferred (foundation metadata concept)
15 Preferred (foundation metadata concept)
15 000 Preferred (foundation metadata concept)
15 000 000 Preferred (foundation metadata concept)
15 885 Preferred (foundation metadata concept)
15 Ch Preferred (foundation metadata concept)
15 minuter efter dosering Preferred (foundation metadata concept)
15,3 Preferred (foundation metadata concept)
15,4 Preferred (foundation metadata concept)
15,75 Preferred (foundation metadata concept)
15,8 Preferred (foundation metadata concept)
15,885 Preferred (foundation metadata concept)
15-hydroperoxi-5,8,11,13-eikosatetraensyra Preferred (foundation metadata concept)
15-hydroxiikosatetraenoatdehydrogenas Preferred (foundation metadata concept)
15-hydroxiprostaglandin-1-dehydrogenas (NADP+) Preferred (foundation metadata concept)
15-hydroxiprostaglandindehydrogenas (NADP^+^) Preferred (foundation metadata concept)
15-hydroxiprostaglandindehydrogenas (NAD^+^) Preferred (foundation metadata concept)
15-oxoprostaglandin-13-reduktas Preferred (foundation metadata concept)
150 Preferred (foundation metadata concept)
150 000 Preferred (foundation metadata concept)
152,4 Preferred (foundation metadata concept)
1537 U Preferred (foundation metadata concept)
154 Preferred (foundation metadata concept)
15q-deletionssyndromet Preferred (foundation metadata concept)
15q11.2-mikrodeletionssyndromet Preferred (foundation metadata concept)
15q11q13-mikroduplikationssyndromet Preferred (foundation metadata concept)
15q13.3-mikrodeletion Preferred (foundation metadata concept)
15q13.3-mikroduplikationssyndromet Preferred (foundation metadata concept)
15q14-mikrodeletionssyndromet Preferred (foundation metadata concept)
15q24-mikrodeletion Preferred (foundation metadata concept)
16 Preferred (foundation metadata concept)
16 000 Preferred (foundation metadata concept)
16 600 Preferred (foundation metadata concept)
16 667 Preferred (foundation metadata concept)
16 800 Preferred (foundation metadata concept)
16 gauge Preferred (foundation metadata concept)
16,1 Preferred (foundation metadata concept)
16,2 Preferred (foundation metadata concept)
16,58 Preferred (foundation metadata concept)
16,7 Preferred (foundation metadata concept)
16,8 Preferred (foundation metadata concept)
16-alfa-hydroxi-dehydroepiandrosteronsulfat Preferred (foundation metadata concept)
16-alfa-hydroxidehydroepiandrosteron Preferred (foundation metadata concept)
16-alfa-hydroxiestron Preferred (foundation metadata concept)
16-alfa-hydroxipregnenolon Preferred (foundation metadata concept)
16-alfa-hydroxisteroiddehydrogenas Preferred (foundation metadata concept)
16-alfahydroxiprogesterondehydratas Preferred (foundation metadata concept)
16-dehydroprogesteronhydratas Preferred (foundation metadata concept)
16-hydroxisteroidepimeras Preferred (foundation metadata concept)
16-metoxi-2,3-dihydro-3-hydroxitabersonin N-metyltransferas Preferred (foundation metadata concept)
16-oxoandrostendiol Preferred (foundation metadata concept)
16/16 Preferred (foundation metadata concept)
16/22 Preferred (foundation metadata concept)
160 Preferred (foundation metadata concept)
162 Preferred (foundation metadata concept)
1627 Burgas Preferred (foundation metadata concept)
165 Preferred (foundation metadata concept)
166 Preferred (foundation metadata concept)
166,667 Preferred (foundation metadata concept)
167 Preferred (foundation metadata concept)
168 Preferred (foundation metadata concept)
16PF-frågeformuläret (16 Personality factor questionnaire) Preferred (foundation metadata concept)
16p11.2-deletionssyndromet Preferred (foundation metadata concept)
16p11.2p12.2-mikrodeletionssyndromet Preferred (foundation metadata concept)
16p11.2p12.2-mikroduplikationssyndromet Preferred (foundation metadata concept)
16p12.2-deletionssyndromet Preferred (foundation metadata concept)
16p13.11-mikrodeletionssyndromet Preferred (foundation metadata concept)
16p13.11-mikroduplikationssyndromet Preferred (foundation metadata concept)
16p13.3-mikroduplikationssyndromet Preferred (foundation metadata concept)
16q24.1-mikrodeletionssyndromet Preferred (foundation metadata concept)
16q24.3-mikrodeletionssyndromet Preferred (foundation metadata concept)
17 Preferred (foundation metadata concept)
17 000 Preferred (foundation metadata concept)
17 500 Preferred (foundation metadata concept)
17 700 Preferred (foundation metadata concept)
17 gauge Preferred (foundation metadata concept)
17,21-dihydroxipregnenolon Preferred (foundation metadata concept)
17,7 Preferred (foundation metadata concept)
17,8 Preferred (foundation metadata concept)
17-O-deacetylvindolin O-acetyltransferas Preferred (foundation metadata concept)
17-alfa-hydroxiprogesteron Preferred (foundation metadata concept)
17-alfahydroxiprogesteronaldolas Preferred (foundation metadata concept)
17-beta-estriol Preferred (foundation metadata concept)
17-hydroxikortikosteroid Preferred (foundation metadata concept)
17-hydroxipregnenolon Preferred (foundation metadata concept)
17-hydroxiprogesteron Preferred (foundation metadata concept)
17-ketogensteroid Preferred (foundation metadata concept)
17-ketosteroid Preferred (foundation metadata concept)

Start Previous Page 11 of 3846 Next End

Reference Sets

Reference set descriptor

Back to Start